Article
Treatment efficacy of pegylated interferon plus ribavirin therapy in chronic hepatitis C patients with mixed genotype 1/2 infection.
Journal of gastroenterology and hepatology - 1 May 2014
Huang Ching-I, Huang Chung-Feng, Huang Jee-Fu, Dai Chia-Yen, Yeh Ming-Lun, Hsieh Ming-Yen, Lin Zu-Yau, Chen Shinn-Cherng, Wang Liang-Yen, Yu Ming-Lung, Chuang Wan-Long
Abstract excerpt
BACKGROUND AND AIM: The treatment efficacy of patients with mixed hepatitis C virus (HCV) genotype 1/genotype 2 (HCV-1/2) remains unknown. We aimed to elucidate the sustained virological response (SVR) rate in patients with HCV-1/2 infection. METHODS: One hundred and ten HCV-1/2 patients treated with response-guided peginterferon/ribavirin therapy (24 weeks for patients with a rapid virological response [RVR] and...
Topics
- Adult
- Antiviral Agents
- Drug Therapy, Combination
- Female
- Genotype
- Hepacivirus
- Hepatitis C, Chronic
- Humans
- Interferon alpha-2
- Interferon-alpha
- Interferons
- Interleukins
- Logistic Models